Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Microalbuminuria. Signification and value]

M Marre1

  • 1Service de Médecine B, Centre hospitalier universitaire, Angers.

Presse Medicale (Paris, France : 1983)
|June 26, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.

Diabetes & metabolism·2020
Same author

Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes.

Diabetes & metabolism·2020
Same author

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).

Diabetes & metabolism·2019
Same author

Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort.

Diabetes & metabolism·2019
Same author

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Diabetes & metabolism·2019
Same author

No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes.

Diabetes & metabolism·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Microalbuminuria, a marker of kidney damage, predicts cardiovascular disease in diabetics and the general population. Early detection of elevated urinary albumin levels is crucial for cardiovascular risk assessment.

Area of Science:

  • Nephrology
  • Cardiology
  • Diabetology

Context:

  • Microalbuminuria signifies elevated urinary albumin, indicating glomerular filter dysfunction.
  • Its prognostic value is well-established in diabetes mellitus for predicting renal disease and cardiovascular mortality.
  • Recent findings highlight its predictive role in cardiovascular morbidity and mortality in the general population, particularly the elderly.

Purpose:

  • To summarize the prognostic significance of microalbuminuria.
  • To explore its predictive value in diabetic and non-diabetic populations.
  • To discuss potential shared pathogenetic mechanisms with atherosclerosis and renal failure.

Summary:

  • Microalbuminuria, defined as a slightly elevated urinary albumin level, indicates impaired kidney filtration.

Related Experiment Videos

  • In diabetics, it predicts renal disease (Type 1) or cardiovascular mortality (Type 2).
  • In the general population, especially the elderly, it predicts cardiovascular morbidity and mortality, likely due to shared pathways with atherosclerosis and renal failure.

    • Impact:

    • Microalbuminuria serves as a critical early biomarker for cardiovascular risk assessment across diverse populations.
    • Understanding its role can lead to improved preventative strategies for cardiovascular and renal diseases.
    • This highlights the interconnectedness of renal health and cardiovascular outcomes.